Antaki Fares, Milad Daniel, Dirani Ali
Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada.
Centre Universitaire d'Ophtalmologie (CUO), Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est-De-l'île-De-Montréal, Montreal, QC, Canada.
Clin Ophthalmol. 2021 Mar 12;15:1129-1131. doi: 10.2147/OPTH.S303551. eCollection 2021.
Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed.
接受抗血管内皮生长因子（anti-VEGF）玻璃体内注射常规治疗新生血管性年龄相关性黄斑变性（nAMD）的患者每次就诊时都要进行散瞳眼底检查（DFE）。在本文中，我们回顾了DFE在指导nAMD确诊患者治疗方面的现有证据，并讨论了随着光学相干断层扫描（OCT）的出现而推迟DFE评估的新型治疗算法。我们还讨论了在当前COVID-19卫生背景下DFE的价值，并强调了必须进行DFE的重要临床情况。
